Gynecomastia Extension Study
NCT00637182
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Gynecomastia
Interventions
DRUG:
Anastrozole
Sponsor
AstraZeneca